Literature DB >> 6474093

Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans.

S Cronberg, E Wallmark, I Söderberg.   

Abstract

Platelet aggregation was investigated in platelet-rich plasma from normal volunteers before and at various times after intake of 10 analgesic drugs. The drugs used were aspirin, piroxicam, naproxen, indomethacin, diclofenac, ibuprofen, diflunisal, paracetamol and oxyphenbutazone. Aggregation of the platelets was induced by adrenaline or ADP and the first and second waves of aggregation were evaluated. It was found that no drug exerted any effect on the first wave of aggregation. The second wave of aggregation was abolished by aspirin that produced a long-lasting effect for 5-8 d. Piroxicam also abolished the second wave of aggregation and this effect persisted on the 2 following d. Naproxen was normalized in half of the volunteers on the 2nd d. The inhibition caused by indomethacin and diclofenac was corrected on the 2nd d. Ibuprofen and diflunisal produced a definite but short-term effect. The effect of salicylic acid was weak. Paracematol and oxyphenbutazone did not affect platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6474093     DOI: 10.1111/j.1600-0609.1984.tb02390.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  28 in total

Review 1.  Do the pharmacodynamics of the nonsteroidal anti-inflammatory drugs suggest a role in the management of postoperative pain?

Authors:  L E Mather
Journal:  Drugs       Date:  1992       Impact factor: 9.546

2.  Historical perspective on ADP-induced platelet activation.

Authors:  Marian A Packham; Margaret L Rand
Journal:  Purinergic Signal       Date:  2011-04-02       Impact factor: 3.765

3.  Accounting for cross boundary flows.

Authors:  J Brazier
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-10

4.  Comparison of Ibuprofen vs Acetaminophen and Severe Bleeding Risk After Pediatric Tonsillectomy: A Noninferiority Randomized Clinical Trial.

Authors:  Gillian R Diercks; Jill Comins; Kara Bennett; Thomas Q Gallagher; Matthew Brigger; Mark Boseley; Philip Gaudreau; Derek Rogers; Jennifer Setlur; Donald Keamy; Michael S Cohen; Christopher Hartnick
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-06-01       Impact factor: 6.223

5.  A randomized, double-blind crossover trial of paracetamol 1000 mg four times daily vs ibuprofen 600 mg: effect on swelling and other postoperative events after third molar surgery.

Authors:  G A Bjørnsson; H R Haanaes; L A Skoglund
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

6.  Unrecognised high pressure chronic retention of urine presenting with systemic arterial hypertension.

Authors:  R R Ghose; V Harindra
Journal:  BMJ       Date:  1989-06-17

7.  Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants.

Authors:  Karen E Corff; Kris C Sekar
Journal:  J Pediatr Pharmacol Ther       Date:  2007-07

8.  Effects of naproxen on the in vivo synthesis of thromboxane and prostacyclin in man.

Authors:  O Vesterqvist; K Gréen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

9.  Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis.

Authors:  C Michael Gibson; Yuri B Pride; Philip E Aylward; Jacques J Col; Shaun G Goodman; Dietrich Gulba; Mijo Bergovec; Vijayalakshmi Kunadian; Cafer Zorkun; Jacqueline L Buros; Sabina A Murphy; Elliott M Antman
Journal:  J Thromb Thrombolysis       Date:  2008-08-10       Impact factor: 2.300

10.  Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.